Cardinal Health announced that it will report its second-quarter financial results for fiscal year 2026 on February 5, prior to the opening of trading on the New York Stock Exchange. The company’s management team will host a live webcast beginning at 8:30 a.m. Eastern Time to discuss key performance metrics, operational highlights and strategic initiatives that drove the quarter’s results.

Investors can access the webcast and accompanying slide presentation without an access code via the Investor Relations section of Cardinal Health’s website. The slide deck and a replay of the webcast will remain available online for 12 months, providing investors and analysts with on-demand access to detailed financial data, segment performance breakdowns and forward-looking commentary.

Cardinal Health operates two primary segments—Pharmaceutical and Medical—serving hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and home-health patients. The Pharmaceutical segment manages distribution of branded, generic and specialty pharmaceuticals and operates nuclear pharmacies and radiopharmaceutical manufacturing facilities. The Medical segment manufactures and distributes exam and surgical gloves, fluid management systems, procedure kits and other single-use products. The company emphasizes a customer-centric approach and data-driven solutions to drive efficiency and innovation across its global supply chain.